H-group (homology)
150.3 4-helical cytokines
Ligands and drugs
1,449
Member domains
153
with ligand contacts (≤ 4 Å)
10.6% of members
154
with DrugDomain annotations
10.6% of members
112
with a DrugBank compound
7.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 150.3 belongs to X-group 150 Ferritin/Heme oxygenase/4-helical cytokines, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 38 |
| DB02555 | FRI | SP4160 | 4 |
| DB02581 | FRH | N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide | 4 |
| DB03453 | FRG | Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate | 2 |
| DB03957 | FRB | SP2456 | 2 |
| DB00852 | — | — | 1 |
| DB01327 | — | — | 1 |
| DB03372 | MHC | 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One | 1 |
| DB03455 | MPE | (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid | 1 |
| DB03567 | A2G | alpha-N-Acetyl-D-galactosamine | 1 |
| DB04278 | NMP | 2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 23 |
| ZNmetal | ZINC ION | 15 |
| CAmetal | CALCIUM ION | 9 |
| NAmetal | SODIUM ION | 7 |
| CL | CHLORIDE ION | 5 |
| IOD | IODIDE ION | 5 |
| NImetal | NICKEL (II) ION | 5 |
| FRH | 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-PENTANOYLAMINO)-ACETYL]-PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL-3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID | 4 |
| FRI | 2-GUANIDINO-4-METHYL-PENTANOIC ACID[2-(4-{5-[4-(4-ACETYLAMINO-BENZYLOXY)-2,3-DICHLORO-PHENYL]-2-METHYL-2H-PYRAZOL-3-YL}-PIPERIDIN-1-YL)-2-OXO-ETHYL]-AMIDE | 4 |
| SMmetal | SAMARIUM (III) ION | 4 |
| MGmetal | MAGNESIUM ION | 3 |
| CMM | 2-[2-(1-CARBAMIMIDOYL-PIPERIDIN-3-YL)-ACETYLAMINO]-3-{4-[2-(3-OXALYL-1H-INDOL-7-YL)ETHYL]-PHENYL}-PROPIONIC ACID METHYL ESTER | 2 |
| FRB | 2-CYCLOHEXYL-N-(2-{4-[5-(2,3-DICHLORO-PHENYL)-2H-PYRAZOL-3-YL]-PIPERIDIN-1-YL}-2-OXO-ETHYL)-2-GUANIDINO-ACETAMIDE | 2 |
| FRG | 2-[3-METHYL-4-(N-METHYL-GUANIDINO)-BUTYRYLAMINO]-3-(4-PHENYLETHYNYL-PHENYL)-PROPIONIC ACID METHYL ESTER | 2 |
| U1metal | URANIUM ATOM | 2 |
| 2JY | 5-[(2,3-dichlorophenoxy)methyl]furan-2-carboxylic acid | 1 |
| 2K1 | 5-methylfuran-2-carboxylic acid | 1 |
| A2G | 2-acetamido-2-deoxy-alpha-D-galactopyranose | 1 |
| ARF | FORMAMIDE | 1 |
| ASN | ASPARAGINE | 1 |